IGF2 and hepatocellular carcinoma: The overlay of the up-regulated genes revealed that PDE4D silencing did not affect the expression of the same genes in the two cell lines, while the analysis of down-regulated genes highlighted that the mRNA expression levels of IGF2, a well-known epigenetic oncodriver in HCC [20], were significantly down-regulated in both HCC cell lines.